Detalhe da pesquisa
1.
Safety and Immunogenicity of Accelerated Heterologous Two-dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa.
Clin Infect Dis
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38657084
2.
Human Polyclonal Antibodies Produced by Transchromosomal Cattle Provide Partial Protection Against Lethal Zaire Ebolavirus Challenge in Rhesus Macaques.
J Infect Dis
; 218(suppl_5): S658-S661, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30053153
3.
Interlaboratory comparison for the Filovirus Animal Nonclinical Group (FANG) anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay.
PLoS One
; 15(8): e0238196, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32841291
4.
An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice.
Hum Vaccin Immunother
; 13(12): 2824-2836, 2017 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28575582
5.
Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges.
Hum Vaccin Immunother
; 11(8): 1991-2004, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25996997
6.
Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses.
PLoS One
; 10(9): e0137786, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26422247
7.
Vaccine generated immunity targets an HPV16 E7 HLA-A2.1-restricted CD8(+) T cell epitope relocated to an early gene or a late gene of the cottontail rabbit papillomavirus (CRPV) genome in HLA-A2.1 transgenic rabbits.
Vaccine
; 29(6): 1194-200, 2011 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21167863